Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997017357) 3-DEOXY-3-DESCLADINOSE DERIVATIVES OF ERYTHROMYCINS A AND B
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/017357 International Application No.: PCT/US1996/017892
Publication Date: 15.05.1997 International Filing Date: 06.11.1996
Chapter 2 Demand Filed: 11.03.1997
IPC:
C07H 17/08 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04
Heterocyclic radicals containing only oxygen as ring hetero atoms
08
Hetero rings containing eight or more ring members, e.g. erythromycins
Applicants:
ABBOTT LABORATORIES [US/US]; CHAD-0377/AP6D-2 One Abbott Park Road Abbott Park, IL 60064-3500, US
Inventors:
OR, Yat, Sun; US
CHU, Daniel, T.; US
ELLIOTT, Richard, L.; US
PIREH, Daisy; US
Agent:
ANAND, Mona ; Abbott Laboratories CHAD 0377/AP6D-2 100 Abbott Park Road Abbott Park, IL 60064-3500, US
Priority Data:
08/729,26910.10.1996US
60/006,34208.11.1995US
Title (EN) 3-DEOXY-3-DESCLADINOSE DERIVATIVES OF ERYTHROMYCINS A AND B
(FR) DERIVES 3-DESOXY-3-DESCLADINOSE DES ERYTHROMYCINES A ET B
Abstract:
(EN) A compound selected from groups (I), (II), and (III), wherein A, B, V, W, X and R8 are specifically defined; pharmaceutical compositions thereof; a method of treating or preventing bacterial infections by administering therapeutically effective pharmaceutical compositions thereof; and a process for the preparation thereof.
(FR) La présente invention concerne un composé sélectionné dans le groupe auquel appartiennent les formules générales (I), (II) et (III). Dans ces formules générales, A, B, V, W, X et R8 sont définis de façon spécifique. L'invention concerne également des compositions pharmaceutiques réalisées à partir de ces dérivés. L'invention concerne en outre une méthode de traitement ou de prévention des infections bactériennes par administration de telles compositions pharmaceutiques thérapeutiquement efficaces. L'invention concerne enfin un procédé de préparation de ces dérivés.
Designated States: AU, CA, IL, JP, KR, MX
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
MXPA/a/1998/003694IL123386EP0874863JP2000501077 CA2235681KR1019990067333
AU1997010744